Daily TIP

Israeli President Reuven Rivlin commends Israel-America alliance on eve of presidential election

Posted by Tip Staff - November 08, 2016


Israeli President Reuven Rivlin addressed the Israel-America Chamber of Commerce Monday night, taking care to reaffirm the unbreakable bond between Israel and the U.S. ahead of the election.
“This evening is not just a chance to celebrate the cooperation, friendship, and the bond between Israel and our greatest most important ally." The president said, “Tonight is a chance to congratulate all the citizens of the United States, on the occasion of the election.” He stressed, “However harsh the arguments, however severe the disagreements, America is the world’s greatest democracy, and whoever wins the election, the real winner is the people, whose voice is heard, and who play a part in shaping their futures.”
The event was also attended by U.S. Ambassador to Israel Dan Shapiro, who thanked the members of the chamber and said, “Since the signing of the US Israel free trade agreement our economic linkages have evolved growing fivefold in the last 31 years to reach $49 billion a year in trade with shared economic benefits for both countries.”


Interpol, the global police agency, rejected a Palestinian bid for membership, The Times of Israel reported Tuesday. The Palestinian Authority was attempting to force a vote on the issue at the organization’s annual conference in Bali, Indonesia, but 62 member states of the global body voted against the Palestinian proposal, with many more abstaining “in a forum where many countries traditionally automatically support the Palestinian agenda,” the Israeli Foreign Ministry and Israeli Police said in a joint statement.
The statement continued, “Once again the Palestinians have tried to politicize an international professional organization...This attempt forms part of the ongoing Palestinian campaign to evade direct negotiations with Israel and to continue the conflict with Israel inside professional international bodies.” Israeli Prime Minister Benjamin Netanyahu stated, “This constitutes a change in Israel’s international standing.”
“Interpol is an important professional organization tasked with helping its members fight crime and ensure public safety,” Israeli Public Security Minister Gilad Erdan said last week. “It cannot be turned into a political body driven by extraneous considerations, as the Palestinians are trying to do.”
The Times of Israel also reported that the Israeli government feared that Interpol’s sensitive information could be leaked to terrorists if the PA became a member.
The Palestinian strategy to avoid bilateral negotiations and instead join international bodies to exert diplomatic pressure on Israel was laid out by PA President Mahmoud Abbas in a 2011 New York Times op-ed. He wrote that the PA sought full membership in the United Nations in order to “internationalize” the conflict and “pave the way for us to pursue claims against Israel at the United Nations, human rights treaty bodies and the International Court of Justice.”
Since then, the Palestinian Authority has hijacked the missions of other international organizations to wage diplomatic war against Israel. Having joined the UN’s cultural agency UNESCO in 2011, the Palestinians and their diplomatic allies have passed two resolutions denying the Jewish and Christian historical connections to Jerusalem, despite continued discovery of archaeological evidence to the contrary.
Scientists have known for 60 years that proton therapy is a superior form of radiation therapy for cancerous tumors, because it allows for zapping diseased cells with higher doses of radiation while significantly reducing damage to healthy surrounding tissue. However, proton therapy has been introduced in only a handful of cancer treatment centers because of the high cost of the machinery and space to house it. Availability could improve dramatically now that a compact, lower-cost device from Israeli company P-Cure has received US Food and Drug Administration (FDA) approval. The patented P-Cure system uses diagnostic-quality computed tomography (CT) to enable proton-therapy treatment planning, positioning and delivery for cancer patients in a seated position. The system is more cost-effective and more therapeutically effective than the current standard of treating the patient in a horizontal position, says Michael Marash, PhD, founder and CEO of P-Cure. The benefits of treating patients in a seated position include greater patient comfort, less internal organ movement, better saliva drainage and a better position for breathing for asthmatic and other patients experiencing impaired breathing,” he explains. “It may also deliver less collateral radiation to sensitive organs while enabling greater accuracy in proton beam delivery.” Adult and pediatric patients with cancers of the lung, breast, chest, lower torso, head and neck can benefit from this clinical breakthrough, Marash adds. The initial American trial of P-Cure was carried out in a Chicago hospital with lung cancer patients. (via Israel21c)

Be the first to comment

Please check your e-mail for a link to activate your account.